Loading...
Dolby Laboratories Inc (DLB) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, insider selling has significantly increased, and the company's recent financial performance shows declines in revenue, net income, and EPS. Additionally, there are no positive news catalysts or significant trading signals to suggest immediate upside potential. Holding off on investing in DLB until more favorable conditions emerge would be prudent.
The MACD is below zero and negatively contracting, indicating bearish momentum. The RSI is neutral at 59.043, and the moving averages suggest a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 65.795, with key support at 63.046 and resistance at 68.543.

No significant positive catalysts identified. No recent news or events to drive the stock upward.
Insider selling has increased by 165.77% over the past month. Financial performance in Q1 2026 shows declines in revenue (-2.88% YoY), net income (-21.37% YoY), and EPS (-21.43% YoY). Gross margin also dropped slightly (-1.17% YoY).
In Q1 2026, Dolby Laboratories reported a revenue decline to $346.7M (-2.88% YoY), net income dropped to $53.3M (-21.37% YoY), and EPS fell to $0.55 (-21.43% YoY). Gross margin decreased slightly to 87.54% (-1.17% YoY).
No recent analyst rating or price target changes are available for DLB.